CANAGLIFLOZIN ANHYDROUS
UNII 6S49DGR869

Substance Identification & Data

This profile provides standardized clinical and technical data for Canagliflozin Anhydrous, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6S49DGR869.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 842133-18-0 and the RxNorm Concept ID (RxCUI) 1546031. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

6S49DGR869

CAS Registry Number

842133-18-0

RxNorm Concept ID

1546031

Detailed Substance Profile

Preferred Name

CANAGLIFLOZIN ANHYDROUS

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

6S49DGR869

The specific atomic composition represented as a molecular structure string.

InChIKey

C24H25FO5S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

XTNGUQKDFGDXSJ-ZXGKGEBGSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C91019

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

24812758

Unique identification number in the NCBI database of chemical substances.

INN ID

9225

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1(cc(Cc2sc(cc2)-c3ccc(cc3)F)c(cc1)C)[C@H]4[C@H](O)[C@H]([C@H](O)[C@H](O4)CO)O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Canagliflozin Anhydrous. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.